Clinical Trial Update: Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating Gardasil 9 is being studied to prevent HPV infection in patients with hematologic malignancies undergoing allogeneic st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm | Phase 4 | Status: ACTIVE_NOT_RECRUITING